Freedom of Information
- Title
- Dermatology Treatments
- Reference Number
- RF23-769
- Request Details
Could you please provide the number of patients treated in the last 4 months, by the dermatology department, with each of the following products:
• Abrocitinib
• Baricitinib
• Dupilumab
• Tralokinumab
• Upadacitinib
- Response
-
- rf23-769-response.pdf
- Date of Disclosure
- 18/12/2023